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Earlier studies from our laboratory demonstrated that the terpolymer of L-glutamic 
acid, L-alanine, and L-tyrosine (GAT) stimulated the development of T  cells capable of 
specifically suppressing  the  antibody responses  in  vivo and  in  vitro  of nonresponder 
strains  (bearing  the  H-2 "~,  H-2 q,  and  H-2"  haplotypes)  to  GAT  complexod  with  an 
immunogenic carrier, methylatod bovine serum albumin, MBSA (1, 2). We then extended 
these findings to another antigen, the copolymer of L-glutamic acid and L-tyrosine (GT). 
None of 19 inbred or congenic resistant mouse strains developed antibody responses to GT 
after immunization with this synthetic polypeptide in adjuvants. All the strains investi- 
gated,  however,  developed IgG plaque-forming  cells  (PFC)  primary  responses  to  GT 
complexed with  MBSA (3).  This permitted us to determine that:  (a)  preimmunization 
with GT suppressed the response to GT-MBSA in certain but not in all strains; (b)  the 
suppression could be transferred by thymocytes and spleen cells from  GT-primed ani- 
mals; (c) the development of GT-specific suppressor cells is under dominant control of H- 
2-1inked  gene(s)  which  have  been  designated  specific  immune  suppressor  genes  (Is 
genes); (d) the Is genes are antigen specific since GAT-MBSA responses are suppressed by 
GAT in strains carrying the H-2 q haplotype, while GT-MBSA responses are not sup- 
pressed by the related polymer GT in these same strains (3, 4). 
The experiments reported in this study map the Is genes responsible for GT- 
specific suppression within the H-2 complex. The data indicate that the K and D 
loci are not concerned with GT-specific suppression, and that this phenomenon 
is controlled by complementing or interacting genes which map on either side of 
cross-over events between the IB and IC subregions. 
Materials and Methods 
Mice.  Mice were purchased from The Jackson Laboratory, Bar Harbor, Maine or the Health 
Research Laboratories, Buffalo, N. Y., or were bred in our animal facilities. Mice used in these 
experiments were 2-8 mo old and were maintained on acidified chlorinated drinking water and 
laboratory chow ad libitum. 
Antigens.  A preparation of GT with molar amino acid ratios Glu~ryr  ~' and average mol wt of 
30,800 daltons was used for immunization. Several preparations of GAT with amino acid ratios 
Glu~°Alaa°Tyr  TM and average mol wt ranging from 35,000 to 47,000 were used for sensitizing sheep 
red cells. All polymers were purchased from Miles Laboratories, Inc., Miles Research Division, 
Elkhart, Ind. 
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MBSA  was prepared according to the method of Sueoka and Cheng (5).  The GT and GAT 
solutions  and the complexes of  these antigens with MBSA  were prepared as  described previously 
(I, 4). 
Immunization.  To investigate the suppressive properties  of GT for different  mouse strains, 
mice were injected  intraperitoneally  initially  with 100  ~g  GT in  a mixture  of  I  nag  magnesium and 
aluminum hydroxides (Maalox, William H. Rorer, Inc.,  Fort Washington, Pa.)  or with Maalox 
alone. 3 days later  the mice were immunized intraperitoneally  with 10 ~g of  GT as GT-MBSA. 
Since our experience demonstrated that different  strains of mice required different  adjuvants 
(complete Freund's or  pertussis  vaccine)  for  optimal PFC responses,  the  appropriate adjuvant was 
selected  for  each  strain  as  indicated  in  the  Tables. When complete  Freund's  adjuvant  was used,  the 
antigen was emulsified with an equal volume of  complete Freund's adjuvant (Difco  Laboratories, 
Detroit,  Mich.).  When pertussis  vaccine was used, mice were injected  with  antigen in  Img Maalox 
with 2 × 10  y  killed  Bordetella  pertussis  organisms (Eli  Lilly  and Co., Indianapolis,  Ind.). 
Hemolytic Plaque Assay.  The antibody response  to GT-MBSA  was assayed 7 days after 
immunization using  a modification  of  the  Jerne hemolytic  plaque technique described  by  Pierce  et 
al. (6).  As  in  previous studies  the  GT-MBSA  response was assayed on  sheep  red  blood cells  coupled 
with the cross-reacting  polymer GAT, GAT-SRBC  (3). 
Since it  was noted in our  previous studies  that the PFC responses in the  spleens to  GT-MBSA 
are restricted  to the IgG class,  the plaques were developed using suitable rabbit antirnouse Ig 
antisera at the appropriate dilution and guinea pig complement as described (3).  GT-specific 
plaques were determined by subtracting the number of PFC remaining after inhibition  by a 
suitable  dilution  of  GAT from the number of  plaques  detected  on  GAT-SRBC  in  the  absence of  the 
specific  inhibitor  (1, 3). All assays were done in duplicate and the number of PFC per spleen 
recorded. 
Results and Discussion 
The ability of a variety of inbred, congenic resistant, and H-2-recombinant 
strains to show suppressed GT-MBSA primary PFC  responses as a  result of 
preimmunization with  GT is  presented  in  Table  I.  The development of GT- 
specific suppression  is  controlled by genes  in  the H-2  complex,  as  reported 
earlier (4). Mouse strains bearing the H-2 k, H-2 ~, or H-2" haplotypes but not H- 
2 ~ or H-2 ~ haplotypes are specifically suppressed by GT preimmunization re- 
gardless  of the  genes contributed by the  B10  or  the A  backgrounds  in  the 
congenic resistant strains. 
A  most  intriguing finding presented  in  Table  I  is  the failure  of GT  to 
suppress GT-MBSA response in the recombinant strains B10.A and A/J and 9R 
and  B10.HTT.  The  B10.A  and  A/J  strains  bear  natural  H-2  recombinants 
between the two "GT suppressor" haplotypes H-2 d and H-2 k, whereas B10.HTT 
is a  recombinant between the "GT suppressor" haplotypes H-2"  and H-2 tl.  In 
addition, the 9R strain is a recombinant comprising the left side of  H-2' and the 
right side of H-2 a (which is thought to be identical to the right side of the "GT 
suppressor" H-2 d haplotype).  The recombinant events in all these strains  oc- 
curred between the IB  and IC subregions. These observations indicate that: (a) 
GT-specific suppression is controlled by at least two complementing or interact- 
ing loci; (b) that there are restrictions in the ability of GT suppressor genes to 
complement when they come from different haplotypes (we shall refer to this 
phenomenon as the requirement for coupled complementation); and (c) that the 
genes responsible for the control of GT-specific suppression are different in H-2 d, 
H-2 k,  and H-2"  suppressor  haplotypes.  The patterns of responsiveness of the 
HTG (Table II) and 7R (Table I) recombinant strains establish that the D locus is 
not concerned with GT-specific suppression.  Conversely the finding that the 274  DEBR~  ET  AL. 
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TABLE  I 
by GT of lgG PFC Responses to GT-MBSA * 
Mice/  H-2  H.2 region formulae  Maalox +  GT +  Suppre~ion of 
Strain  GT-MBSA  GT-MBSA  the GT-MBSA  P  value 
group  type  K  IA  IB  IC  S  D  (mean -+ SE)  (mean ± SE)  response 
PFC  /spleen  PFC  /spleen  % 
BALB/c  48  d  d  d  d  d  d  d  12,658  .+ 750  2,566 ± 492  80  <0.000001 
B10.D2  4  d  d  d  d  d  d  d  9,187 -+ 977  3,325 -+  1,920  64  <0.03 
BI0.BR  16  k  k  k  k  k  k  k  7,765 ± 1,133  1,371  +- 496  82  <0.00001 
C57BR  8  k  k  k  k  k  k  k  10,334  ±  1,819  3,346 -+  1,018  68  <0.006 
SJL  16  s  s  s  s  s  s  s  10,401 .+ 887  3,012 -+- 652  71  <0.000001 
B10.S  9  s  s  s  s  s  s  s  6,358 .+  2,178  847 -+ 355  87  <0.01 
A.SW  12  s  s  s  s  s  s  s  8,500 +- 1,300  2,800 .+ 800  67  <0.001 
A.BY  8  b  b  b  b  b  b  b  11,079  ±  2,174  14,286  +- 2,179  0  NS 
B10  7  b  b  b  b  b  b  b  14,489  -+ 3,147  13,096  -+ 2,351  10  NS 
A/J  27  a  k  k  kl  d  d  d  9,021 -+ 894  10,315 .+  982  0  NS 
B10.A  8  a  k  k  kl  d  d  d  12,118  ±  1,746  15,631  -  3,398  0  NS 
9R  11  t4  s  s  s [  d  d  d  8,677 +- 2,441  6,406 +- 1,644  26  NS 
B10.HTT  14  t3  s  s  s I  k  k  d  8,119 .+  1,197  8,446 -+  1,012  0  NS 
HTG  10  g  d  d  d  d  d I  b  15,807  ±  1,922  3,117 -+  1,258  80  <0.00003 
7R  10  t2  s  s  s  s  s  I  d  5,817 -+ 1,205  725 +- 310  88  <0.0006 
A.TL  8  tl  s [  k  k  k  k  d  10,693  +- 2,322  3,196 ±  1,326  71  <0.01 
NS, not significant. Vertical bar indicates location of crossing over event. 
*100 ~tg of  GT or Maalox alone was administered intraperitoneally, followed 3 days later by 10 ~zg ofGT complexed  with MBSA. 7 days later 
the number of specific IgG PPC per spleen were counted using GAT-coated  SRBC. All strains except B10, B10.D2, B10.S,  B10.A,  and 7R 
were  immunized with complete Freund's adjuvant. B10,  B10.D2,  B10.S,  B10.A,  and 7R mice were immunized using Maalox and B. 
pertuss/~ as adjuvant. 
TABLE  II 
Gene Complementation  in the Trans Position  Controlling  GT-Specific  Suppression* 
Strain  Mice/  H-2  H-2 region formulae  Maalox +  GT +  Suppression 
GT-MBSA  GT-MBSA  GT-MBSA  P  value 
group  type  K  IA  IB  IC  S  D  (Mean  .+ SE)  (Mean -+ SE)  response 
PFC  /spleen  PFC  Ispleen  % 
! 
HTG  10  g  d  d  d  d  dl  b  15,807  ,+  1,922  3,117 .+  1,258  80  <0.00003 
D2.GD  10  g4  d  dl  b  b  b  b  13,140  -~  1,312  11,397  -+ 2,563  14  NS 
BI0.A  8  a  k  k  kl  d  d  d  12,118  ~  1,746  15,631  ± 3,398  0  NS 
(D2.GD x  11  g4/a  d/k  d/k  b/k  b/d  b/d  bid  7,243 .+ 1,087  3,544 _+ 1,312  51  <0.04 
B10.A}F~ 
NS, not significant. Vertical bar indicates location of crossing over event. 
* Immunization doses  and procedures  were the same as described in Table I.  HTG and D2.GD  swains were immunized with complete 
Fraund's adjuvant. B10.A and (D2.GD  x  B10.A)F~ were immunized with Maalox and B. pertussis as adjuvant. 
A.TL strain  can be suppressed in its  GT-MBSA  response by GT preimmuniza- 
tion  rules  out  a contribution  by the  K locus  to  this  phenomenon and establishes 
that  the  complementing suppressor  genes  map in  the  I  and/or  S regions  of  the  H- 
2 complex and more probably in the I region,  known to be concerned with the 
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presented in Table II suggest that, when genes from the same "suppressor' 
H-2  d haplotype capable of complementation  for GT-specific suppression are 
found in the trans configuration  as in the (D2.GD  x  B10.A)FI, GT-specific 
suppression of  GT-MBSA  primary PFC responses can be observed. Collectively, 
these various experiments may be interpreted to indicate that complementing 
genes in  I-C and genes in  I-A and/or  I-B are responsible for  the development of 
GT-specific suppression. This situation is, in several respects, analogous with 
the genetic control of  antibody responses (8)  and of  in vitro  stimulation of  DNA 
synthesis (9) in animals immunized with the terpolymer of  L-glutamic acid, L- 
lysine, and L-phenylalanine (GI~) except that in the case of  the GL~ Ix genes, 
complementation  was  demonstrable  by  the responsiveness  of recombinant 
strains  derived from strains bearing nonresponder haplotypes (8);  in  the case of 
GT Is  genes, we are  faced  with the  reverse situation,  i.e.,  recombinants between 
strains  bearing suppressor haplotypes fail  to  show suppression and yet  cannot be 
demonstrated  to behave as unequivocal GT responder strains (3).  The data 
imply, therefore, a very close  if  not, as yet, an absolute reverse relationship 
between the control of  specific  responsiveness and specific  suppression by com- 
plementing l-region genes. The close  relationship between Ix  and Is  genes is  also 
supported by the observations that (a) weak but definite  T-cell  helper activity 
has been reported ih  GAT nonresponder strains  under appropriate experimental 
conditions (10);  and (b) the development of  transient PFC responses to GT in 
nonresponder H-2  d  BALB/c mice treated with an appropriate dose of  cyclophos- 
phamide known to destroy suppressor T-cell  activity  (11). 
The ability  of  preimmunization with GAT  or  GT to  suppress the  response of 
genetic nonresponder strains to GAT-MBSA  or GT-MBSA,  respectively,  can be 
transferred by antigen-specific  factors  obtained from thymocytes or spleen cells 
from animals primed with the copolymers (12,  and footnote 1).  The complemen- 
tary genes concerned with the control  of  GT-specific suppression could control 
the synthesis and/or release of  the suppressor factor or its ability  to exert its 
regulatory activity  on cells  of  the  immune system. Studies in  progress to  explore 
these possibilities  suggest strain restrictions  in the ability  of  GAT-specific and 
GT-specific suppressor factors  to  exert their effects  in  recipient  animals (12,  and 
footnote 1). 
Received for publication I April 1976. 
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